Search results - 12 results
Linkage of individual-patient data confirm protection of prophylactic human papillomavirus vaccination against invasive cervical cancer
HPV human papillomavirus patient data Vaccination Abstract: INTRODUCTION The Scottish study of Palmer et al., published in the current issue of this journal, linking vaccination files with cervical ...
Clinical performance of the novel full-genotyping OncoPredict HPV Quantitative Typing assay using the VALGENT framework.
Cuschieri, Kate; M. Arbyn Source: Int J Cancer, Volume 154, Issue 3 (2024) Keywords: Adult Early Detection of Cancer Female Genotype Genotyping Techniques Humans middle aged Papillomaviridae Papillomavirus ...
Human papillomavirus negative high grade cervical lesions and cancers: Suggested guidance for HPV testing quality assurance
Publication Type: Peer reviewed scientific article Authors: Prétet, Jean Luc; Arroyo Mühr, Laila Sara; Cuschieri, Kate; Fellner, María Dolores; Correa, Rita Mariel; Picconi, María Alejandra; Garland, Suzanne M.; Murray, Gerald L.; Molano, Monica; Michael ...
Can REALQUALITY RQ-HPV screen be considered as a clinically validated HPV test for use in cervical cancer screening?
Detection of Cancer Female Humans Mass Screening Papillomaviridae Papillomavirus Infections Uterine Cervical Dysplasia Uterine Cervical Neoplasms Vaginal Smears Abstract: “Can REALQUALITY RQ- HPV screen be ...
HPV-based Cervical Cancer Screening on Self-samples in the Netherlands: Challenges to Reach Women and Test Performance Questions.
E Source: Cancer Epidemiol Biomarkers Prev, Volume 32, Issue 2 (2023) Keywords: Early Detection of Cancer Female Humans Mass Screening Netherlands Papillomaviridae Papillomavirus Infections specimen handling ...
Evaluation of the clinical performance of OncoPredict HPV® SCR assay within the VALGENT‐2 framework
Kate; M. Arbyn Source: Journal of Medical Virology, Volume 95, Issue 1 (2023) Keywords: cervical cancer HPV genotyping human papillomavirus OncoPredict HPV® test validation. VALGENT Abstract: Human ...
Accuracy of high-risk HPV DNA PCR, p16(INK4a) immunohistochemistry or the combination of both to diagnose HPV-driven oropharyngeal cancer
HPV mRNA; Oropharyngeal carcinoma; HPV-AHEAD Abstract: Background The incidence of high-risk human papillomavirus (hrHPV)-driven head and neck squamous cell carcinoma, in particular oropharyngeal ...
HPV DNA genotyping, HPV E6*I mRNA detection, and p16INK4a/Ki-67 staining in Belgian head and neck cancer patient specimens, collected within the HPV-AHEAD study
80 and over Alphapapillomavirus Belgium Cyclin-Dependent Kinase Inhibitor p16 DNA, Viral Female Genotype Head and Neck Neoplasms Head and neck neoplasms; Human papillomavirus; Human papillomavirus DNA ...
Age-specific vaccination coverage estimates for influenza, human papillomavirus and measles containing vaccines from seven population-based healthcare databases from four EU countries – The ADVANCE project
Publication Type: Peer reviewed scientific article Authors: Toon Braeye; Hanne-Dorthe Emborg; Ana Llorente-García; Consuelo Huerta; Elisa Martín-Merino; Talita Duarte-Salles; Giorgia Danieli; Lara Tramontan; Daniel Weibel; Chris McGee; Marco Villa; Rosa G ...
Age-specific vaccination coverage estimates for influenza, human papillomavirus and measles containing vaccines from seven population-based healthcare databases from four EU countries – The ADVANCE project
Publication Type: Peer reviewed scientific article Authors: Toon Braeye; Hanne-Dorthe Emborg; Ana Llorente-García; Consuelo Huerta; Elisa Martín-Merino; Talita Duarte-Salles; Giorgia Danieli; Lara Tramontan; Daniel Weibel; Chris McGee; Marco Villa; Rosa G ...